Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma (r/r NHL) research hub

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination with Glofitamab in Participants with Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma

This study is looking at a new treatment called RO7443904, used with another medicine called glofitamab. It's for people in the UK with a type of blood cancer called B-Cell Non-Hodgkin’s Lymphoma that has come back or not responded to previous treatments. Researchers want to see if it's safe and helps people.